Dual-aptamer-engineered M1 macrophage with enhanced specific targeting and checkpoint blocking for solid-tumor immunotherapy
2022 · Molecular Therapy · 28 citations
https://doi.org/10.1016/j.ymthe.2022.04.015
M
Minkang Guo
First Affiliated Hospital of Chongqing Medical University(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
20
Papers
256
Citations
9
h-index
9
i10-index
Minkang Guo is an academic researcher from First Affiliated Hospital of Chongqing Medical University. The author has contributed to research in topics: Immune cells in cancer & Bone and Joint Diseases & Extracellular vesicles in disease. The author has an h-index of 9, co-authored 17 publications.
ORCID: 0000-0002-5316-256XPapers by this author
worksQualitative Histopathological Classification of Primary Bone Tumors Using Deep Learning: A Pilot Study
2021 · Frontiers in Oncology · 18 citations
https://doi.org/10.3389/fonc.2021.735739
IL-27 regulates macrophage ferroptosis by inhibiting the Nrf2/HO1 signaling pathway in sepsis-induced ARDS
2025 · Inflammation Research · 9 citations
https://doi.org/10.1007/s00011-024-01986-2
Dual-aptamer-engineered M1 macrophage with enhanced specific targeting and checkpoint blocking for solid-tumor immunotherapy
2024 · Molecular Therapy · 3 citations
https://doi.org/10.1016/j.ymthe.2024.06.024
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat